EP2861576
BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1
:
EP einkaleyfi: Þýðing ekki lögð inn:
9.5.2013:
10.1.2018:
13730655.1
:
8.5.2033
:
BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1
9.5.2013
10.1.2018
:
Novartis AG:
Lichtstrasse 35, 4056, Basel, CH
:
FURET, Pascal:
Basel, CH
:
GROTZFELD, Robert Martin:
Basel, CH
:
JONES, Darryl Brynley:
Basel, CH
:
MANLEY, Paul:
Basel, CH
:
MARZINZIK, Andreas:
Basel, CH
:
PELLE, Xavier Francois Andre:
Basel, CH
:
SALEM, Bahaa:
Basel, CH
:
SCHOEPFER, Joseph:
Basel, CH
:
JAHNKE, Wolfgang:
Basel, CH
:
201261647174 P:
15.5.2012:
US
:
201361789842 P:
15.3.2013:
US
:
IB2013053771:
9.5.2013
:
C07D 401/04, C07D 401/14, C07D 403/10, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/10, C07D 417/14, A61K 31/4439, A61K 31/444, A61K 31/496, A61K 31/5377, A61P 31/00